A Longitudinal Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy

  • STATUS
    Recruiting
  • participants needed
    218
  • sponsor
    National Cancer Center, Korea
Send
Updated on 16 February 2024
See if I qualify
cancer
cancer treatment

Summary

  1. Based on the literature, the pancreatic cancer treatment predictor biomarker, which is used in the domestic clinical field, is actually applied to the pancreatic cancer patient cohort of the National Cancer Center.
  2. To systematically prospectively identify prospective treatment response biomarkers for Pancreatic Cancer Cohort in the National Cancer Center

Description

  1. Immunohistochemistry and gene test for hENT1, DCK, SMAD4, CES2, BRCA 1/2,PALB2, MMRd, MSI, Tumor Ag and etc. on Cancer sample
  2. Collect data of Biomarker for pancreatic cancer
  3. Compare with Big data and Cohort study in National cancer center

Details
Condition Pancreatic Cancer, Pancreatic Cancer, Pancreatic disorder, Neoplasm of unspecified nature of digestive system
Age 100years or below
Clinical Study IdentifierNCT04281511
SponsorNational Cancer Center, Korea
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Pathologically Confirmed Pancreatic Cancer Patients

Exclusion Criteria

Subjects who do not agree with the study
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

cancer
cancer treatment

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.